









Markets
/
Stocks
/
nasdaq-cor
/

Cencora Inc

COR

291.630USD

-10.890-3.60%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

56.54BMarket Cap

29.80P/E TTM



Cencora Inc

291.630

-10.890-3.60%

Overview Company Financials Analysis

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Company Info

Ticker SymbolCOR

Company nameCencora Inc

IPO dateMay 28, 1996

CEODr. Robert P. (Bob) Mauch, Ph.D.

Number of employees42000

Security typeOrdinary Share

Fiscal year-endMay 28

Address1 West First Avenue

CityCONSHOHOCKEN

Stock exchangeNYSE Consolidated

CountryUnited States of America

Postal code19428

Phone16107277000

Websitehttps://www.cencora.com/

Ticker SymbolCOR

IPO dateMay 28, 1996

CEODr. Robert P. (Bob) Mauch, Ph.D.

Company Executives

Name

Name/Position

Position

Shareholding

Change

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

307.91K

-0.65%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.71K

+0.31%

Mr. Dennis M. Nally

Independent Director

12.53K

+0.98%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

11.35K

-26.17%

Mr. Werner Baumann

Independent Director

3.02K

+4.35%

Dr. Lorence H. Kim, M.D.

Independent Director

957.00

+469.64%

Ms. Lori J. Ryerkerk

Independent Director

516.00

Ms. Lauren M. Tyler

Independent Director

Mr. Bennett S. Murphy

Senior Vice President, Investor Relations

Name

Name/Position

Position

Shareholding

Change

Mr. Steven H. (Steve) Collis, CPA

Executive Chairman of the Board

307.91K

-0.65%

Mr. Lon R. Greenberg

Independent Director

19.11K

-13.57%

Ms. Elizabeth S. Campbell

Executive Vice President, Chief Legal Officer

14.71K

+0.31%

Mr. Dennis M. Nally

Independent Director

12.53K

+0.98%

Ms. Silvana Battaglia

Chief Human Resources Officer, Executive Vice President

11.35K

-26.17%

Mr. Werner Baumann

Independent Director

3.02K

+4.35%

Revenue Breakdown

No Data

No Data

By Business

By Region

No Data

Shareholding Stats

Updated: Sat, Aug 16

Shareholders

Shareholder Types

Shareholders

Proportion

The Vanguard Group, Inc.

11.55%

BlackRock Institutional Trust Company, N.A.

6.21%

State Street Global Advisors (US)

4.34%

Walgreens Boots Alliance Inc

3.85%

T. Rowe Price Associates, Inc.

3.85%

Other

70.20%

Shareholders

Proportion

The Vanguard Group, Inc.

11.55%

BlackRock Institutional Trust Company, N.A.

6.21%

State Street Global Advisors (US)

4.34%

Walgreens Boots Alliance Inc

3.85%

T. Rowe Price Associates, Inc.

3.85%

Other

70.20%

Shareholder Types

Shareholders

Proportion

Investment Advisor

49.64%

Investment Advisor/Hedge Fund

29.43%

Hedge Fund

4.35%

Corporation

3.86%

Research Firm

3.45%

Pension Fund

2.80%

Bank and Trust

2.26%

Sovereign Wealth Fund

1.30%

Family Office

1.17%

Other

1.75%

Institutional Shareholding

Updated: Tue, Jul 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q2

2306

191.45M

98.75%

-197.41K

2025Q1

2293

192.45M

99.29%

-2.90M

2024Q4

2214

199.54M

103.03%

-6.12M

2024Q3

2134

200.05M

102.56%

+474.02K

2024Q2

2090

200.10M

100.34%

-7.14M

2024Q1

2068

201.37M

100.95%

-1.37M

2023Q4

1982

202.46M

101.40%

+179.01K

2023Q3

1885

197.70M

97.79%

-2.16M

2023Q2

1870

195.01M

96.41%

-1.88M

2023Q1

1823

192.70M

95.24%

-7.51M

Shareholder Activity

Name

Shares Held

Proportion

Change

Chg %

Date

The Vanguard Group, Inc.

21.28M

10.98%

+51.74K

+0.24%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

11.01M

5.68%

+234.21K

+2.17%

Mar 31, 2025

State Street Global Advisors (US)

8.41M

4.34%

+382.24K

+4.76%

Mar 31, 2025

Walgreens Boots Alliance Inc

9.62M

4.96%

-765.00K

-7.37%

Jun 09, 2025

T. Rowe Price Associates, Inc.

9.33M

4.81%

+724.11K

+8.41%

Mar 31, 2025

Geode Capital Management, L.L.C.

4.50M

2.32%

+177.32K

+4.10%

Mar 31, 2025

Boston Partners

5.41M

2.79%

+404.09K

+8.07%

Mar 31, 2025

Wellington Management Company, LLP

5.42M

2.8%

+363.40K

+7.18%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.03M

1.05%

+334.08K

+19.67%

Mar 31, 2025

Managed Account Advisors LLC

2.65M

1.37%

+243.08K

+10.10%

Mar 31, 2025

Related ETFs

Updated: Sat, Sep 6

Name

Proportion

VanEck Pharmaceutical ETF

5.23%

AdvisorShares Focused Equity ETF

4.8%

First Trust Consumer Staples Alphadex Fund

4.03%

Invesco Dorsey Wright Healthcare Momentum ETF

3.74%

Janus Henderson Mid Cap Growth Alpha ETF

3.67%

VanEck Retail ETF

3.26%

First Trust Dorsey Wright Momentum & Low Vol ETF

2.6%

American Century Mid Cap Growth Impact ETF

2.55%

iShares US Consumer Staples ETF

2.41%

ProShares Pet Care ETF

2.2%

VanEck Pharmaceutical ETF

Proportion5.23%

AdvisorShares Focused Equity ETF

Proportion4.8%

First Trust Consumer Staples Alphadex Fund

Proportion4.03%

Invesco Dorsey Wright Healthcare Momentum ETF

Proportion3.74%

Janus Henderson Mid Cap Growth Alpha ETF

Proportion3.67%

VanEck Retail ETF

Proportion3.26%

First Trust Dorsey Wright Momentum & Low Vol ETF

Proportion2.6%

American Century Mid Cap Growth Impact ETF

Proportion2.55%

iShares US Consumer Staples ETF

Proportion2.41%

ProShares Pet Care ETF

Proportion2.2%

Dividend

A total of 1.92B USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

Feb 05, 2025

COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025

Feb 14, 2025

Mar 03, 2025

Feb 14, 2025

Nov 06, 2024

COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024

Nov 15, 2024

Nov 29, 2024

Nov 15, 2024

Jul 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024

Aug 09, 2024

Aug 26, 2024

Aug 09, 2024

May 01, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024

May 10, 2024

May 24, 2024

May 09, 2024

Jan 31, 2024

COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024

Feb 09, 2024

Feb 26, 2024

Feb 08, 2024

Nov 02, 2023

COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Nov 27, 2023

Nov 10, 2023

Aug 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023

Aug 11, 2023

Aug 28, 2023

Aug 10, 2023

May 02, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023

May 12, 2023

May 30, 2023

May 11, 2023

Feb 01, 2023

COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023

Feb 10, 2023

Feb 27, 2023

Feb 09, 2023

Nov 04, 2022

COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022

Nov 14, 2022

Nov 28, 2022

Nov 10, 2022

Stock Split

Date

Type

Ratio

No Data

Date

Type

Ratio

No Data

KeyAI

